The Repeated Hepatectomy for Frequent Recurrence of Hepatic Metastasis from Gastrointestinal Stromal Tumor of the Stomach

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 181-183

  Sato, Takahiro ^a   Ohyama, Shigekazu ^a,b   Kokudo, Norihiko ^a   Suenaga, Mitsukuni ^a   Yamamoto, Junji ^a   Yamaguchi, Toshiharu ^a   Muto, Tetsuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Dept of Gastrointestinal Surgery ^*  (Japan)

Author keywords

Gastrointestinal stromal tumor; Liver metastasis; Repeated hepatectomy

Indexed keywords

ALCOHOL;

AGED; ARTICLE; BLEEDING; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; MEDICAL EXAMINATION; PARTIAL GASTRECTOMY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; TREATMENT OUTCOME;

FATAL OUTCOME; HEPATECTOMY; HUMANS; LEIOMYOSARCOMA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; STOMACH NEOPLASMS;

EID: 10744224184     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lang H, Nusbaum K, Kaudel P, Fruhauf N, Flemming P, Raab R: Hepatic metastases from leiomyosarcoma. A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231:500-505.
2. Dematteo RP, Yuman Fong ASBS, Jmagin WR, Blumgart LH, Brennan MF: Results of hepatic resection for sarcoma metastatic liver. Ann Surg 2001; 234:540-548.
3. Kindblom LG, Remotti HE, Aidenborg F, Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of cajal. Am J Pathol 1998; 152:1259-1269.
4. Jaffe BM, Donegan WL, Watson F, Spratt JS: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127:1-11.
5. Ng EH, Plollock RE, Romsdahl MM: Prognostic implications of patterns of failure for gastrointestinal leiomyosarcoma. Cancer 1992; 69:1334-1341.
6. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localized respectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997; 350:1647-1654.
7. Le Cesne A, Judson I, Crowther D, Rodenhuis S, Keizer HJ, Van Hoesel Q, Blay JY, Frisch J, Van Glabbeke M, Hermans C, Van Oosterom A, Tursz T, Verweij J: Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. J Clin Oncol 2000; 18(14):2676-2684.
8. Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M, Demachi H, Miwa A: Strategy for pancreatic endocrine tumors. Hepatogastroenterology 2000; 47:540-544.
9. Mavligit GM, Zukwiski AA, Ellis LM, Chuang VP, Wallace S: Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 1995; 75(8):2083-2088.
10. Penn I: Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110:726-734.
11. O'Grady JG, Poison RJ, Rolles K, Calne RY, Williams R: Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1998; 207:373-379.
12. Jaques DP, Coit DG, Casper ES, Brennan MF: Hepatic metastases from soft-tissue sarcoma. Ann Surg 1995; 221:392-397.
13. Sato T, Konishi K, Yabushita K, Nojima N, Kimura H, Maeda K, Tsuji M, Miwa A: The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection - Analysis of total course following primary resection of colorectal cancer. Int Surg 1998; 83:340-342.
14. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344(14):1052-1056.